Replies to post #215206 on Biotech Values

[ronpopeil]

RVNC Revance Therapeutics (RVNC) Granted FDA Orphan Status for Treatment of Cervical Dystonia

[DewDiligence]

RVNC—Tweet series re primary/secondary endpoints in SAKURA-1/2 trials:

https://twitter.com/DewDiligence/status/935606856441098240 [expand the view, if necessary, to see all of the tweets in the series]

There’s a lot of confusion out there about these endpoints!